Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Capital Leases: 2011-2021

Historic Capital Leases for Adma Biologics (ADMA) over the last 3 years, with Mar 2021 value amounting to $6.4 million.

  • Adma Biologics' Capital Leases rose 250.48% to $6.4 million in Q1 2021 from the same period last year, while for Mar 2021 it was $6.4 million, marking a year-over-year increase of 250.48%. This contributed to the annual value of $4.3 million for FY2020, which is N/A change from last year.
  • According to the latest figures from Q1 2021, Adma Biologics' Capital Leases is $6.4 million, which was up 48.12% from $4.3 million recorded in Q4 2020.
  • Adma Biologics' Capital Leases' 5-year high stood at $6.4 million during Q1 2021, with a 5-year trough of $15,319 in Q1 2017.
  • Over the past 3 years, Adma Biologics' median Capital Leases value was $1.8 million (recorded in 2020), while the average stood at $2.8 million.
  • Data for Adma Biologics' Capital Leases shows a peak YoY surged of 953.41% (in 2019) over the last 5 years.
  • Adma Biologics' Capital Leases (Quarterly) stood at $15,319 in 2017, then reached $119,080 in 2018, then soared by 953.41% to $1.4 million in 2019, then surged by 110.91% to $4.3 million in 2020, then soared by 250.48% to $6.4 million in 2021.
  • Its Capital Leases was $6.4 million in Q1 2021, compared to $4.3 million in Q4 2020 and $2.9 million in Q3 2020.